Jasper Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JSPR and other ETFs, options, and stocks.

About JSPR

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.

CEO

Ronald A. Martell

CEORonald A. Martell

Employees

Employees64

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2018

Founded2018

Employees

Employees64

JSPR Key Statistics

Market cap

48.13M

Market cap48.13M

Price-Earnings ratio

-0.29

Price-Earnings ratio-0.29

Dividend yield

—

Dividend yield—

Average volume

1.18M

Average volume1.18M

High today

$1.77

High today$1.77

Low today

$1.66

Low today$1.66

Open price

$1.70

Open price$1.70

Volume

506.94K

Volume506.94K

52 Week high

$23.11

52 Week high$23.11

52 Week low

$1.39

52 Week low$1.39

Stock Snapshot

Jasper Therapeutics(JSPR) stock is priced at $1.69, giving the company a market capitalization of 48.13M. It carries a P/E multiple of -0.29.

As of 2025-12-17, Jasper Therapeutics(JSPR) stock has fluctuated between $1.66 and $1.77. The current price stands at $1.69, placing the stock +1.8% above today's low and -4.5% off the high.

Jasper Therapeutics(JSPR) shares are trading with a volume of 506.94K, against a daily average of 1.18M.

During the past year, Jasper Therapeutics(JSPR) stock moved between $1.39 at its lowest and $23.11 at its peak.

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own JSPR. This list is generated using Robinhood data, and it’s not a recommendation.